Shopping Cart 0
Cart Subtotal
USD 0

Mayo Clinic - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in most of the major disease categories and health disorders. It conducts active human research studies and new human research studies approved by institutional review at its facilities. The organization also operates several colleges of medicine which offer various residency and fellowship programs. Its other major facilities include Mayo Arizona, Mayo Minnesota, and Mayo Clinic Health System, a network of clinics and hospitals in several states. Mayo is headquartered in Jacksonville, Florida, the US.

Mayo Clinic-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12

Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

Mayo Clinic, Pharmaceuticals & Healthcare, Deal Details 19

Venture Financing 19

Helix Opco Raises USD200 Million in Series B Financing 19

Unity Biotech Raises Additional USD35 Million in Series B Financing 21

Qrativ Raises USD8.3 Million in Series A Financing 23

Evelo Biosciences Raises USD50 Million in Series B Financing 24

DayTwo Secures USD12 Million in Series A Funding 26

DayTwo Raises USD12 Million in Series A Financing 27

UNITY Biotech Raises USD116 Million in Series B Financing 28

Second Genome Raises USD42.6 Million in Series B Financing 30

Unity Biotechnology Raises Funds in Venture Financing 32

AssureRx Health Raises Additional USD15 Million in Series D Financing 33

AssureRx Health Raises USD30 Million in Venture Financing Round 34

Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 36

Seres Health Raises USD10 Million in Series B Financing 38

AssureRx Health Raises USD7 Million in Venture Financing 40

OxThera Raises USD 10.7 Million In Venture Financing 42

Omnis Pharma Raises Funds in Seed Financing 43

AssureRx Health Raises USD 12.5 Million In Series C Financing 44

Partnerships 46

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 46

SkylineDx Enters into Co-Development Agreement with Mayo Clinic 48

Sphingotec Enters into Collaboration Agreement with Mayo Clinic 49

Mayo Clinic and nference Form Joint Venture 50

Baxter International and Mayo Clinic Enter into Research Agreement 51

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 52

EnBiotix Partners with Mayo Clinic 53

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 54

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 55

GE Ventures Forms Joint Venture with Mayo Clinic 56

Morphotek Enters into Agreement with Mayo Clinic 57

Mayo Clinic Forms Joint Venture with Hillhouse Capital 58

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 59

Mayo Clinic Forms Joint Venture with Delos Living 60

Enterome Enters into Co-Development Agreement with Mayo Clinic 61

Seres Health Enters into Research Agreement with Mayo Clinic 62

Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 63

Mayo Clinic Forms Joint Venture With Cancer Genetics 64

Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 66

Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 67

Optum Enters Into Joint Venture Agreement With Mayo Clinic 68

Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 69

Licensing Agreements 70

Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 70

Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 71

Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 72

Mayo Clinic Enters into Licensing Agreement with ID Pharma 74

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 75

Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 76

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 77

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 78

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 79

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 80

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 81

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 82

Acquisition 83

Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 83

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 84

Mayo Clinic-Key Competitors 85

Mayo Clinic-Key Employees 86

Mayo Clinic-Locations And Subsidiaries 87

Head Office 87

Other Locations & Subsidiaries 87

Joint Venture 89

Recent Developments 90

Strategy And Business Planning 90

Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 90

Sep 06, 2018: Mayo Clinic joins hospitals to launch a not-for-profit generic drug company 91

May 10, 2018: Vyriad to Build State-of-the-Art Facility for Manufacturing Oncolytic Virus Anti-Cancer Vaccines in Rochester, Minn. 92

Jul 14, 2017: Mayo Clinic, nference Launch a Startup to Discover, Develop Treatments for Diseases with Unmet Medical Need 93

Corporate Communications 95

Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo's board of trustees also names two new members 95

Legal and Regulatory 98

Jun 25, 2018: Court Agrees with Atrium Health, Rejecting Attempt by Mednax to Disrupt Transition to New Anesthesia Partner 98

Jan 09, 2018: FDA clears way for Mayo Clinic to accelerate production of stem cells for clinical trials through automation 99

Government and Public Interest 100

Oct 10, 2018: Mayo Clinic researchers identify gene types driving racial disparities in myeloma 100

Oct 10, 2018: Columbia scientist Anthony Fitzpatrick and collaborators awarded USD 7.8M to identify new targets against brain disease 101

Oct 10, 2018: Mayo Clinic researchers study immunity-boosting vaccine to target aggressive form of breast cancer 102

Oct 08, 2018: Mayo Clinic Researchers Question Benefits of Long Term Oxygen Therapy in COPD 103

Oct 02, 2018: Liver transplant, weight-loss surgery combination benefits obese patients in long term 104

Oct 01, 2018: NIH, DoD to develop Limb Loss and Preservation Registry 105

Sep 28, 2018: Mayo Clinic researchers receive specialized program of Research Excellence grant for liver and biliary cancer from the National Cancer Institute 106

Sep 20, 2018: Opioid controlled substance agreements safely reduce health care visits Mayo study finds 107

Sep 18, 2018: New COPD guidelines from international panel provide updated recommendations 108

Aug 01, 2018: Number of opioid prescriptions remains unchanged, Mayo Clinic research finds 109

Jul 30, 2018: FSU faculty awarded USD 226M in research dollars 111

Jul 25, 2018: Drug for Alzheimer's disease shows early promise 112

Jun 21, 2018: Unusually High Levels of Herpesviruses Found in the Alzheimer's Disease Brain, Mount Sinai Researchers Report 113

Jun 19, 2018: Mayo Clinic discovers gene mutations linked to pancreatic cancer, calls for expanded testing 115

May 31, 2018: Hyundai Hope On Wheels Announces Four Quantum Award Grant Recipients To Receive A Total Funding Of USD 5.5 Million Towards Pediatric Cancer Research 116

May 23, 2018: Foundation for Anesthesia Education and Research Awards USD 1.4 million in Grants 118

May 18, 2018: Biotin supplements caused misleading test results, almost led to unnecessary procedure 121

May 01, 2018: Mayo Clinic joins NIH in launching All of Us Research Program 122

Feb 21, 2018: Early results from clinical trials not all they're cracked up to be, shows new research 123

Jan 25, 2018: Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers 124

Jan 17, 2018: Patients with blood cancer precursor at risk of developing cancer even after 30 years 125

Jan 03, 2018: Research finds hysterectomy alone associated with increased long-term health risks 126

Dec 11, 2017: USC, Harvard-affiliated hospitals & Mayo Clinic team up to streamline Alzheimer's research 127

Nov 01, 2017: New Study Links Severe Hot Flashes With Greater Risk of Obstructive Sleep Apnea 129

Oct 24, 2017: Proton therapy may be better option for elderly patients with esophageal cancer 130

Sep 25, 2017: Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes 131

Sep 18, 2017: Scientists Discover Novel Mechanism Underlying ALS and Related Dementia 132

Aug 29, 2017: Study finds hormone therapy improves sleep quality for recently menopausal women 133

Aug 25, 2017: Study identifies genes linked to better immune response to flu vaccine 134

May 02, 2017: Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight cancer, prevent recurrence 135

Jan 09, 2017: Mayo Clinic researchers identify new potential treatment for cancer metastasis 136

Product News 137

Nov 20, 2017: New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows 137

Nov 01, 2017: Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer 139

10/04/2018: Mayo researchers identify potential new treatment for subset of women with triple-negative breast cancer 140

Jul 09, 2018: Senolytics Improve Health, Extend life: Preclinical research findings 141

Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 142

May 16, 2018: Mayo study identifies new potential treatment option for triple negative breast cancer 143

May 16, 2018: Mayo discovery means individualized ovarian, brain cancer therapies 144

May 03, 2017: Mayo Clinic-invented technologies show brain tumor firmness, adhesion before surgery 145

Mar 08, 2018: Mayo Clinic's clinical trial matching project sees higher enrollment in breast cancer trials through use of artificial intelligence 146

Other Significant Developments 147

Oct 23, 2018: Mayo Clinic national health checkup: most Americans would choose an alternative to opioids following surgery 147

Oct 09, 2018: Mayo Clinic first to perform CAR T-cell therapy in NE Florida 149

Sep 27, 2018: ImmunogenX completes CypCel trial for celiac disease 150

Sep 13, 2018: Viruses show new promise in treating cancer 151

Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 153

Jun 15, 2018: Mayo Clinic brings national Smithsonian exhibit to Rochester Art Center 154

Apr 03, 2018: Mayo Clinic to coordinate new effort to expand medical research, expert care for Lewy body dementia patients 155

Appendix 156

Methodology 156

About GlobalData 156

Contact Us 156

Disclaimer 156


List Of Figure

List of Figures

Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12


List Of Table

List of Tables

Mayo Clinic, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Mayo Clinic, Deals By Therapy Area, 2012 to YTD 2018 11

Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12

Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

Helix Opco Raises USD200 Million in Series B Financing 19

Unity Biotech Raises Additional USD35 Million in Series B Financing 21

Qrativ Raises USD8.3 Million in Series A Financing 23

Evelo Biosciences Raises USD50 Million in Series B Financing 24

DayTwo Secures USD12 Million in Series A Funding 26

DayTwo Raises USD12 Million in Series A Financing 27

UNITY Biotech Raises USD116 Million in Series B Financing 28

Second Genome Raises USD42.6 Million in Series B Financing 30

Unity Biotechnology Raises Funds in Venture Financing 32

AssureRx Health Raises Additional USD15 Million in Series D Financing 33

AssureRx Health Raises USD30 Million in Venture Financing Round 34

Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 36

Seres Health Raises USD10 Million in Series B Financing 38

AssureRx Health Raises USD7 Million in Venture Financing 40

OxThera Raises USD 10.7 Million In Venture Financing 42

Omnis Pharma Raises Funds in Seed Financing 43

AssureRx Health Raises USD 12.5 Million In Series C Financing 44

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 46

SkylineDx Enters into Co-Development Agreement with Mayo Clinic 48

Sphingotec Enters into Collaboration Agreement with Mayo Clinic 49

Mayo Clinic and nference Form Joint Venture 50

Baxter International and Mayo Clinic Enter into Research Agreement 51

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 52

EnBiotix Partners with Mayo Clinic 53

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 54

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 55

GE Ventures Forms Joint Venture with Mayo Clinic 56

Morphotek Enters into Agreement with Mayo Clinic 57

Mayo Clinic Forms Joint Venture with Hillhouse Capital 58

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 59

Mayo Clinic Forms Joint Venture with Delos Living 60

Enterome Enters into Co-Development Agreement with Mayo Clinic 61

Seres Health Enters into Research Agreement with Mayo Clinic 62

Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 63

Mayo Clinic Forms Joint Venture With Cancer Genetics 64

Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 66

Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 67

Optum Enters Into Joint Venture Agreement With Mayo Clinic 68

Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 69

Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 70

Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 71

Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 72

Mayo Clinic Enters into Licensing Agreement with ID Pharma 74

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 75

Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 76

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 77

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 78

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 79

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 80

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 81

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 82

Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 83

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 84

Mayo Clinic, Key Competitors 85

Mayo Clinic, Key Employees 86

Mayo Clinic, Other Locations 87

Mayo Clinic, Subsidiaries 87

Mayo Clinic, Joint Venture 89

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in most of the major disease categories and health disorders. It conducts active human research studies and new human research studies approved by institutional review at its facilities. The organization also operates several colleges of medicine which offer various residency and fellowship programs. Its other major facilities include Mayo Arizona, Mayo Minnesota, and Mayo Clinic Health System, a network of clinics and hospitals in several states. Mayo is headquartered in Jacksonville, Florida, the US.

Mayo Clinic-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12

Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

Mayo Clinic, Pharmaceuticals & Healthcare, Deal Details 19

Venture Financing 19

Helix Opco Raises USD200 Million in Series B Financing 19

Unity Biotech Raises Additional USD35 Million in Series B Financing 21

Qrativ Raises USD8.3 Million in Series A Financing 23

Evelo Biosciences Raises USD50 Million in Series B Financing 24

DayTwo Secures USD12 Million in Series A Funding 26

DayTwo Raises USD12 Million in Series A Financing 27

UNITY Biotech Raises USD116 Million in Series B Financing 28

Second Genome Raises USD42.6 Million in Series B Financing 30

Unity Biotechnology Raises Funds in Venture Financing 32

AssureRx Health Raises Additional USD15 Million in Series D Financing 33

AssureRx Health Raises USD30 Million in Venture Financing Round 34

Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 36

Seres Health Raises USD10 Million in Series B Financing 38

AssureRx Health Raises USD7 Million in Venture Financing 40

OxThera Raises USD 10.7 Million In Venture Financing 42

Omnis Pharma Raises Funds in Seed Financing 43

AssureRx Health Raises USD 12.5 Million In Series C Financing 44

Partnerships 46

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 46

SkylineDx Enters into Co-Development Agreement with Mayo Clinic 48

Sphingotec Enters into Collaboration Agreement with Mayo Clinic 49

Mayo Clinic and nference Form Joint Venture 50

Baxter International and Mayo Clinic Enter into Research Agreement 51

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 52

EnBiotix Partners with Mayo Clinic 53

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 54

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 55

GE Ventures Forms Joint Venture with Mayo Clinic 56

Morphotek Enters into Agreement with Mayo Clinic 57

Mayo Clinic Forms Joint Venture with Hillhouse Capital 58

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 59

Mayo Clinic Forms Joint Venture with Delos Living 60

Enterome Enters into Co-Development Agreement with Mayo Clinic 61

Seres Health Enters into Research Agreement with Mayo Clinic 62

Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 63

Mayo Clinic Forms Joint Venture With Cancer Genetics 64

Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 66

Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 67

Optum Enters Into Joint Venture Agreement With Mayo Clinic 68

Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 69

Licensing Agreements 70

Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 70

Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 71

Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 72

Mayo Clinic Enters into Licensing Agreement with ID Pharma 74

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 75

Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 76

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 77

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 78

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 79

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 80

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 81

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 82

Acquisition 83

Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 83

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 84

Mayo Clinic-Key Competitors 85

Mayo Clinic-Key Employees 86

Mayo Clinic-Locations And Subsidiaries 87

Head Office 87

Other Locations & Subsidiaries 87

Joint Venture 89

Recent Developments 90

Strategy And Business Planning 90

Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 90

Sep 06, 2018: Mayo Clinic joins hospitals to launch a not-for-profit generic drug company 91

May 10, 2018: Vyriad to Build State-of-the-Art Facility for Manufacturing Oncolytic Virus Anti-Cancer Vaccines in Rochester, Minn. 92

Jul 14, 2017: Mayo Clinic, nference Launch a Startup to Discover, Develop Treatments for Diseases with Unmet Medical Need 93

Corporate Communications 95

Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo's board of trustees also names two new members 95

Legal and Regulatory 98

Jun 25, 2018: Court Agrees with Atrium Health, Rejecting Attempt by Mednax to Disrupt Transition to New Anesthesia Partner 98

Jan 09, 2018: FDA clears way for Mayo Clinic to accelerate production of stem cells for clinical trials through automation 99

Government and Public Interest 100

Oct 10, 2018: Mayo Clinic researchers identify gene types driving racial disparities in myeloma 100

Oct 10, 2018: Columbia scientist Anthony Fitzpatrick and collaborators awarded USD 7.8M to identify new targets against brain disease 101

Oct 10, 2018: Mayo Clinic researchers study immunity-boosting vaccine to target aggressive form of breast cancer 102

Oct 08, 2018: Mayo Clinic Researchers Question Benefits of Long Term Oxygen Therapy in COPD 103

Oct 02, 2018: Liver transplant, weight-loss surgery combination benefits obese patients in long term 104

Oct 01, 2018: NIH, DoD to develop Limb Loss and Preservation Registry 105

Sep 28, 2018: Mayo Clinic researchers receive specialized program of Research Excellence grant for liver and biliary cancer from the National Cancer Institute 106

Sep 20, 2018: Opioid controlled substance agreements safely reduce health care visits Mayo study finds 107

Sep 18, 2018: New COPD guidelines from international panel provide updated recommendations 108

Aug 01, 2018: Number of opioid prescriptions remains unchanged, Mayo Clinic research finds 109

Jul 30, 2018: FSU faculty awarded USD 226M in research dollars 111

Jul 25, 2018: Drug for Alzheimer's disease shows early promise 112

Jun 21, 2018: Unusually High Levels of Herpesviruses Found in the Alzheimer's Disease Brain, Mount Sinai Researchers Report 113

Jun 19, 2018: Mayo Clinic discovers gene mutations linked to pancreatic cancer, calls for expanded testing 115

May 31, 2018: Hyundai Hope On Wheels Announces Four Quantum Award Grant Recipients To Receive A Total Funding Of USD 5.5 Million Towards Pediatric Cancer Research 116

May 23, 2018: Foundation for Anesthesia Education and Research Awards USD 1.4 million in Grants 118

May 18, 2018: Biotin supplements caused misleading test results, almost led to unnecessary procedure 121

May 01, 2018: Mayo Clinic joins NIH in launching All of Us Research Program 122

Feb 21, 2018: Early results from clinical trials not all they're cracked up to be, shows new research 123

Jan 25, 2018: Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers 124

Jan 17, 2018: Patients with blood cancer precursor at risk of developing cancer even after 30 years 125

Jan 03, 2018: Research finds hysterectomy alone associated with increased long-term health risks 126

Dec 11, 2017: USC, Harvard-affiliated hospitals & Mayo Clinic team up to streamline Alzheimer's research 127

Nov 01, 2017: New Study Links Severe Hot Flashes With Greater Risk of Obstructive Sleep Apnea 129

Oct 24, 2017: Proton therapy may be better option for elderly patients with esophageal cancer 130

Sep 25, 2017: Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes 131

Sep 18, 2017: Scientists Discover Novel Mechanism Underlying ALS and Related Dementia 132

Aug 29, 2017: Study finds hormone therapy improves sleep quality for recently menopausal women 133

Aug 25, 2017: Study identifies genes linked to better immune response to flu vaccine 134

May 02, 2017: Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight cancer, prevent recurrence 135

Jan 09, 2017: Mayo Clinic researchers identify new potential treatment for cancer metastasis 136

Product News 137

Nov 20, 2017: New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows 137

Nov 01, 2017: Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer 139

10/04/2018: Mayo researchers identify potential new treatment for subset of women with triple-negative breast cancer 140

Jul 09, 2018: Senolytics Improve Health, Extend life: Preclinical research findings 141

Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 142

May 16, 2018: Mayo study identifies new potential treatment option for triple negative breast cancer 143

May 16, 2018: Mayo discovery means individualized ovarian, brain cancer therapies 144

May 03, 2017: Mayo Clinic-invented technologies show brain tumor firmness, adhesion before surgery 145

Mar 08, 2018: Mayo Clinic's clinical trial matching project sees higher enrollment in breast cancer trials through use of artificial intelligence 146

Other Significant Developments 147

Oct 23, 2018: Mayo Clinic national health checkup: most Americans would choose an alternative to opioids following surgery 147

Oct 09, 2018: Mayo Clinic first to perform CAR T-cell therapy in NE Florida 149

Sep 27, 2018: ImmunogenX completes CypCel trial for celiac disease 150

Sep 13, 2018: Viruses show new promise in treating cancer 151

Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 153

Jun 15, 2018: Mayo Clinic brings national Smithsonian exhibit to Rochester Art Center 154

Apr 03, 2018: Mayo Clinic to coordinate new effort to expand medical research, expert care for Lewy body dementia patients 155

Appendix 156

Methodology 156

About GlobalData 156

Contact Us 156

Disclaimer 156


List Of Figure

List of Figures

Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12


List Of Table

List of Tables

Mayo Clinic, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Mayo Clinic, Deals By Therapy Area, 2012 to YTD 2018 11

Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12

Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

Helix Opco Raises USD200 Million in Series B Financing 19

Unity Biotech Raises Additional USD35 Million in Series B Financing 21

Qrativ Raises USD8.3 Million in Series A Financing 23

Evelo Biosciences Raises USD50 Million in Series B Financing 24

DayTwo Secures USD12 Million in Series A Funding 26

DayTwo Raises USD12 Million in Series A Financing 27

UNITY Biotech Raises USD116 Million in Series B Financing 28

Second Genome Raises USD42.6 Million in Series B Financing 30

Unity Biotechnology Raises Funds in Venture Financing 32

AssureRx Health Raises Additional USD15 Million in Series D Financing 33

AssureRx Health Raises USD30 Million in Venture Financing Round 34

Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 36

Seres Health Raises USD10 Million in Series B Financing 38

AssureRx Health Raises USD7 Million in Venture Financing 40

OxThera Raises USD 10.7 Million In Venture Financing 42

Omnis Pharma Raises Funds in Seed Financing 43

AssureRx Health Raises USD 12.5 Million In Series C Financing 44

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 46

SkylineDx Enters into Co-Development Agreement with Mayo Clinic 48

Sphingotec Enters into Collaboration Agreement with Mayo Clinic 49

Mayo Clinic and nference Form Joint Venture 50

Baxter International and Mayo Clinic Enter into Research Agreement 51

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 52

EnBiotix Partners with Mayo Clinic 53

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 54

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 55

GE Ventures Forms Joint Venture with Mayo Clinic 56

Morphotek Enters into Agreement with Mayo Clinic 57

Mayo Clinic Forms Joint Venture with Hillhouse Capital 58

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 59

Mayo Clinic Forms Joint Venture with Delos Living 60

Enterome Enters into Co-Development Agreement with Mayo Clinic 61

Seres Health Enters into Research Agreement with Mayo Clinic 62

Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 63

Mayo Clinic Forms Joint Venture With Cancer Genetics 64

Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 66

Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 67

Optum Enters Into Joint Venture Agreement With Mayo Clinic 68

Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 69

Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 70

Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 71

Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 72

Mayo Clinic Enters into Licensing Agreement with ID Pharma 74

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 75

Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 76

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 77

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 78

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 79

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 80

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 81

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 82

Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 83

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 84

Mayo Clinic, Key Competitors 85

Mayo Clinic, Key Employees 86

Mayo Clinic, Other Locations 87

Mayo Clinic, Subsidiaries 87

Mayo Clinic, Joint Venture 89

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS